Alzamend Neuro Stock (NASDAQ: ALZN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 55.837K |
Day Range | - - - |
52 Wk Range | 0.652 - 11.910 |
Market Cap | $4.844M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 0.9% |
Days to Cover | 1.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alzamend Neuro (NASDAQ: ALZN) through any online brokerage.
Other companies in Alzamend Neuro’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), NexImmune (NASDAQ:NEXI), Genprex (NASDAQ:GNPX) and Portage Biotech (NASDAQ:PRTG).
The latest price target for Alzamend Neuro (NASDAQ: ALZN) was reported by Maxim Group on Wednesday, April 12, 2023. The analyst firm set a price target for 1.50 expecting ALZN to rise to within 12 months (a possible 112.65% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Alzamend Neuro (NASDAQ: ALZN) is $0.7054 last updated April 24, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Alzamend Neuro.
Alzamend Neuro’s Q4 earnings are confirmed for Thursday, July 25, 2024.
There is no upcoming split for Alzamend Neuro.
Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.